Goldman Sachs Pharma Stocks Growth Plan October 2021

INVESTMENT DESCRIPTION

CURRENCY GBP

STRIKE DATE 29/10/2021

ISIN XS2359487027

COUNTERPARTY Goldman Sachs

TYPE Plan

RETURN & BARRIERS
Maximum Term: 5 years
Investment Structure: Reducing Autocall
Autocall Opportunities: Annually (First observation at 12 months)
Autocall Trigger: 100% of Initial Level (Reducing to 95% for Year 3 & 90% for Year 4 & 5)
Payment: GBP = 8.00% Annually
Capital Risk: Not capital protected
Capital Protection Barrier: 65% Final level of the FTSE 100 (Observed at maturity only)

MATURITY DATE
29/10/2026

BACK

DOWNLOADS

DISCLAIMER

IDAD Limited, formed in 2002, has developed a reputation as a Structured Product powerhouse. Our approach is based on capital preservation first, with growth or income opportunities structured to suit different market conditions.

Terms and Conditions of use

This website constitutes a financial promotion and has been issued and approved for the purpose of section 21 of the Financial Services and Markets Act 2000 by IDAD Limited. IDAD Limited is authorised and regulated by the Financial Conduct Authority FCA FRN 740499. IDAD is a limited company registered in England and Wales number 4521366.

The purpose of this website is to inform Independent Financial Advisors (“IFAs”) and other professional intermediaries of the products and services offered by IDAD Limited. The information in this website should not be considered as an offer to purchase securities, and nothing stated within this website constitutes advice.

Neither this website nor any documents contained within it constitutes investment advice or an offer or solicitation to sell in any jurisdiction in which an offer, solicitation, purchase or sale would be unlawful under the securities law of that jurisdiction. The material contained within is purely for information purposes and its accuracy cannot be guaranteed. Investments may go up or down in value and you may lose some or all of the amount invested. Past performance is not necessarily a guide for the future. Returns from the structured products are at risk in the event of any of the institutions who provide securities for these products default on their financial obligations. Any decision to invest should be based on the information contained in the relevant term sheet or prospectus (and any supplements thereto) of the relevant product which includes information on certain risks associated with an investment.

By accessing this website you represent that you are permitted by the laws of your jurisdiction of residence to access this site and the information contained herein.

This website is not intended for residents of the United States as we are not authorised to sell our products and services in the USA.

IDAD Ltd does not give advice on the suitability of its products to private retail investors.

This website is confidential, and no part of it may be reproduced, distributed or transmitted without the prior written permission of IDAD Limited.

Our Website uses Cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won’t work without them. By using our website you accept our use of cookies.

We will not be liable for any loss or damage arising out of or in connection with the use of this site.

(1) I HAVE READ UNDERSTOOD AND ACCEPT THIS DISCLAIMER AND

(2) I CONFIRM THAT I AM NOT A RESIDENT OF THE UNITED STATES AND UNDERSTAND (A) THAT THE INFORMATION THAT FOLLOWS IS ONLY BEING OFFERED TO AND IS ONLY INTENDED TO BE AVAILABLE TO PERSONS WHO ARE NOT RESIDENTS OF THE UNITED STATES AND (B) THAT IDAD LTD AND ITS AFFILIATES WILL RELY ON THE ACCURACY OF THIS INFORMATION

(3) I CONFIRM I AM A PROFESSIONAL CLIENT OR ELIGIBLE COUNTERPARTY (as defined by the FCA)

Remember me